Govt was responding to question on availability of safety & efficacy data for Corbevax, and whether it had been peer-reviewed. It sidestepped queries on efficacy & peer-review.
Hyderabad-based Biological E has priced its vaccine at Rs 990 in the private market. For the government, however, the vaccine is at just Rs 145, making it very affordable.
It will be used in six other states too. Corbevax of Biological E is also expected to start coming in this month. No decision so far on the government procuring Covovax.
A Q&A with vaccine scientist Peter Hotez, author of 'Preventing the Next Pandemic', on developing a low-cost Covid vaccine, and why Omicron won’t be the end of the pandemic.
Corbevax co-developer Dr Peter Hotez says the vaccine will 'make up for lost time' in race to immunise millions and its patent was waived in the spirit of 'decolonisation'.
India granted emergency-use authorisation to two new Covid vaccines, Corbevax and Covovax, this week. Both use proteins of the coronavirus to induce an immune response.
The creation of Viksit armed forces requires a national security vision for 2047, a national security strategy reviewed every five years, and a national defence policy.
Arbitrage fund managers are bracing for lower returns after govt raised taxes on equity derivatives. Arbitrage funds gained traction in India last yr as foreign investors exited equities.
Defence Acquisition Council likely to take up P-8I procurement, cleared in 2019, in third week this month. Proposed joint production of GE F414-INS6 engine also on agenda.
The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.
COMMENTS